Epidemiology of Ischemic Stroke

Neurologic Clinics

Volumn 34, Issue 4, 2016, Pages 967-980

  Favate, Albert S ^a   Younger, David S ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Epidemiology; Public health; Stroke

Indexed keywords

BRAIN ISCHEMIA; BRAIN RADIOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; ETHNICITY; GENOME-WIDE ASSOCIATION STUDY; HEREDITY; HUMAN; LACUNAR STROKE; MIGRAINE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; RACE; REVIEW; WHITE MATTER LESION; GENETICS; STROKE;

GENOME-WIDE ASSOCIATION STUDY; HUMANS; STROKE;

EID: 84991759852     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2016.06.013     Document Type: Review

References (72)

1. Feigin, V.L., Mensah, G.A., Norrving, B., et al. GBD 2013 Stroke Panel Experts Group. Atlas of the Global Burden of Stroke (1990-2013): the GBD 2013 Study. Neuroepidemiology 45 (2015), 230–236.
2. Sacco, R.L., Boden-Albala, B., Gan, R., et al. Stroke incidence among white, black and Hispanic residents of an urban community. Am J Epidemiol 147 (1998), 259–268.
3. Bureau of the Census, 1990 census of population and housing. 1990, Bureau of the Census; US Department of Commerce, Washington, DC.
4. Community Health Profiles, Take care New York. Inwood and Washington Heights. 2nd edition, 2006, New York City Department of Health and Mental Hygiene, Manhattan (NY).
5. Jacobs, B.S., Boden-Albala, B., Lin, I.F., et al. Stroke in the young in the northern Manhattan stroke Study. Stroke 33 (2002), 2789–2793.
6. Sacco, R.L., Elkind, M., Boden-Albala, B., et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 281 (1999), 53–60.
7. Elkind, M.S., Sciacca, R., Boden-Albala, B., et al. Moderate alcohol consumption reduced risk of ischemic stroke: the Northern Manhattan Study. Stroke 37 (2006), 13–19.
8. Sacco, R.L., Boden-Albala, B., Abel, G., et al. Race-ethnic disparities in the impact of stroke risk factors: the Northern Manhattan Stroke Study. Stroke 32 (2011), 1725–1731.
9. Gardener, H., Wright, C.B., Gu, Y., et al. Mediterranean style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr 94 (2011), 1458–1464.
10. Boden-Albala, B., Elkind, M.S., White, H., et al. Dietary total fat intake and ischemic stroke risk: the Northern Manhattan Study. Neuroepidemiology 32 (2009), 296–301.
11. Boden-Albala, B., Sacco, R.L., Lee, H.S., et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke 39 (2008), 30–35.
12. Willey, J.Z., Moon, Y.P., Kahn, E., et al. Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the Northern Manhattan Study. J Am Heart Assoc, 3, 2014, e00106.
13. Goldstein, L.B., Adams, R., Alberts, M.J., et al. Primary prevention of ischemic stroke. A guidelines from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113 (2006), e873–e923.
14. Sacco, R.L., Newer risk factors for stroke. Neurology 57:Suppl 2 (2001), S31–S34.
15. Sacco, R.L., Gan, R., Boden-Albala, B., et al. Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke 29 (1998), 380–387.
16. Sacco, R.L., Benson, R.T., Kargman, D.E., et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 285 (2001), 2729–2735.
17. Kargman, D.E., Berglund, L.F., Boden-Albala, B., et al. Increased stroke risk and lipoprotein (a) in a racially mixed area: the Northern Manhattan Stroke Study. Stroke, 30, 1999, 251.
18. Sacco, R.L., Roberts, J.K., Jacobs, B.S., Homocysteine as a risk factor for ischemic stroke: an epidemiological story in evolution. Neuroepidemiology 17 (1998), 167–173.
19. Kissela, B.M., Khoury, J., Kleindorfer, D., et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 28 (2005), 355–359.
20. Fine-Edelstein, J.S., Wolf, P.A., O'Leary, D.H., et al. Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology 44 (1994), 1046–1050.
21. Sutton-Tyrrell, K., Alcorn, H.G., Wolfson, S.K. Jr., et al. Predictors of carotid stenosis in older adults with and without systolic hypertension. Stroke 24 (1993), 355–361.
22. Jeng, J.S., Sacco, R.L., Kargman, D.E., et al. Apolipoproteins and carotid artery atherosclerosis in an elderly multiethnic population: the Northern Manhattan stroke study. Atherosclerosis 165 (2002), 317–325.
23. Foulkes, M.A., Wolf, P.A., Price, T.R., et al. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 19 (1988), 547–554.
24. Adams, H.P. Jr., Bendixen, B.H., Kappelle, L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke 24 (1993), 35–41.
25. Moncayo, J., Devuyst, G., Van Melle, G., et al. Coexisting causes of ischemic stroke. Arch Neurol 57 (2000), 1139–1144.
26. Moulin, T., Tatu, L., Crépin-Leblond, T., et al. The Besançon Stroke Registry: an acute stroke registry of 2,500 consecutive patients. Eur Neurol 38 (1997), 10–20.
27. Kumral, E., Ozkaya, B., Sagduyu, A., et al. The Ege Stroke Registry: a hospital-based study in the Aegean region, Izmir, Turkey. Analysis of 2,000 stroke patients. Cerebrovasc Dis 8 (1998), 278–288.
28. Yip, P.K., Jeng, J.S., Lee, T.K., et al. Subtypes of ischemic stroke. A hospital-based stroke registry in Taiwan (SCAN-IV). Stroke 28 (1997), 2507–2512.
29. Mohr, J.P., Biller, J., Hilal, S.K., et al. Magnetic resonance versus computed tomographic imaging in acute stroke. Stroke 26 (1995), 807–812.
30. Adams, H.P. Jr., del Zoppo, G., Alberts, M.J., et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115 (2007), e478–e534.
31. Wintermark, M., Fiebach, J., Imaging of brain parenchyma in stroke. Handb Clin Neurol 94 (2009), 1011–1019.
32. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. N Engl J Med 333 (1995), 1581–1587.
33. Jansen, O., Schellinger, P., Fiebach, J., et al. Early recanalization in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet 353 (1999), 2036–2037.
34. Dominiczak, A.F., McBride, M.W., Genetics of common polygenic stroke. Nat Genet 35 (2003), 116–117.
35. Brass, L.M., Isaacsohn, J.L., Merikangas, K.R., et al. A study of twins and stroke. Stroke 23 (1992), 221–223.
36. Brass, L.M., Shaker, L.A., Family history in patients with transient ischemic attacks. Stroke 22 (1991), 837–841.
37. Sacco, R.L., Benjamin, E.J., Broderick, J.P., et al. American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke. Risk factors. Stroke 28 (1997), 1507–1517.
38. Duggirala, R., Villalpando, C.G., O'Leary, D.H., et al. Genetic basis of variation in carotid artery wall thickness. Stroke 27 (1996), 833–837.
39. Catto, A.J., Genetic aspects of the hemostatic system in cerebrovascular disease. Neurology 57:Suppl 2 (2001), S24–S30.
40. Hindorff, L.A., Sethupathy, P., Junkins, H.A., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106 (2009), 9362–9367.
41. Tan, M.S., Jiang, T., Tan, J., et al. Genome-wide association studies in neurology. Ann Transl Med, 2(12), 2014, 124.
42. Gretarsdottir, S., Thorleifsson, G., Manolescu, A., et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol 64 (2008), 402–409.
43. Gudbjartsson, D.R., Holm, H., Gretarsdottir, S., et al. A sequence variant in ZFHX3 on 16q22 associated with atrial fibrillation and ischemic stroke. Nat Genet 41 (2009), 876–878.
44. Gschwendtner, A., Bevan, S., Cole, J.W., et al. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol 65 (2009), 531–539.
45. Kubo, M., Hata, J., Ninomiya, T., et al. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 39 (2007), 212–217.
46. Traylor, M., Farrall, M., Holliday, E.G., et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol 11 (2012), 951–962.
47. Bersano, A., Ballabio, E., Bresolin, N., et al. Genetic polymorphisms for the study of multifactorial stroke. Hum Mutat 29 (2008), 776–795.
48. Campbell, D.J., Woodward, M., Chalmers, J.P., et al. Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. Arch Neurol 63 (2006), 60–65.
49. Ikram, M.A., Seshadri, S., Bis, J.C., et al. Genome-wide association studies of stroke. N Engl J Med 360 (2009), 1718–1728.
50. International Stroke Genetics Consortium, Wellcome Trust Case-Control Consortium 2. Failure to validate association between 12p13 variants and ischemic stroke. N Engl J Med 362 (2010), 1547–1550.
51. Rubattu, S., Volpe, M., Kreutz, R., et al. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet 13 (1996), 429–434.
52. Terni, E., Giannini, N., Brondi, M., et al. Genetics of ischaemic stroke in young adults. BBA Clin 3 (2014), 96–106.
53. Sharma, P., Yadav, S., Meschia, J.F., Genetics of ischaemic stroke. J Neurol Neurosurg Psychiatry 84 (2013), 1302–1308.
54. Kalimo, H., Viitanen, M., Amberla, K., et al. CADASIL: hereditary disease of arteries causing brain infarcts and dementia. Neuropathol Appl Neurobiol 25 (1999), 257–265.
55. Shah, S., Ellard, S., Kneen, R., et al. Childhood presentation of COL4A1 mutations. Dev Med Child Neurol 54 (2012), 569–574.
56. Schiffmann, R., Fabry disease. Pharmacol Ther 122 (2009), 65–77.
57. Debette, S., Markus, H.S., The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ, 341, 2010, c3666.
58. Rost, N.S., Rahman, R.M., Biffi, A., et al. White matter hyperintensity volume is increased in small vessel stroke subtypes. Neurology 75 (2010), 1670–1677.
59. Arsava, E.M., Rahman, R., Rosand, J., et al. Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke. Neurology 72 (2009), 1403–1410.
60. Hofer, E., Cavalieri, M., Bis, J.C., et al., Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. White matter lesion progression: genome-wide search for genetic influences. Stroke 46 (2015), 3048–3057.
61. Verhaaren, B.F., Debette, S., Bis, J.C., et al. Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet 8 (2015), 398–409.
62. Traylor, M., Zhang, C.R., Adib-Samil, P., et al., International Stroke Genetics Consortium. Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke. Neurology 86 (2016), 146–153.
63. Traylor, M., Bevan, S., Baron, J.C., et al. Genetic architecture of lacunar stroke. Stroke 46 (2015), 2407–2412.
64. Launer, L.J., Terwindt, G.M., Ferrari, M.D., The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 53 (1999), 537–542.
65. Kurth, T., Chabriat, H., Bousser, M.G., Migraine and stroke: a complex association with clinical implications. Lancet Neurol 11 (2012), 92–100.
66. Etminan, M., Takkouche, B., Isorna, F.C., et al. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ, 330, 2005, 63.
67. Schurks, M., Rist, P.M., Bigal, M.E., et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ, 339, 2009, b3914.
68. Nozari, A., Dilekoz, E., Sukhotinsky, I., et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol 67 (2010), 221–229.
69. Stam, A.H., Haan, J., van den Maagdenberg, A.M., et al. Migraine and genetic and acquired vasculopathies. Cephalalgia 29 (2009), 1006–1017.
70. Zeller, J.A., Frahm, K., Baron, R., et al. Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke?. J Neurol Neurosurg Psychiatry 75 (2004), 984–987.
71. Friberg, L., Olesen, J., Lassen, N.A., et al. Cerebral oxygen extraction, oxygen consumption, and regional cerebral blood flow during the aura phase of migraine. Stroke 25 (1994), 974–979.
72. Malik, R., Freilinger, T., Winsvold, B.S., et al. Shared genetic basis for migraine and ischemic stroke. A genome-wide analysis of common variants. Neurology 84 (2015), 2132–2145.